马拉维糖尿病视网膜病变和黄斑水肿筛查与激光治疗的增量成本效益分析

包含马拉维糖尿病视网膜病变和黄斑水肿筛查与激光治疗的增量成本效益分析数据,基于357名患者队列的马尔可夫模型。

Figshare
2018-01-05 更新
浏览 21
表格service utilization ratescreeninglaser photocoagulation treatmentlaser treatmentbase case scenariobase casemacular edemainterventionretinopathyQALYdisability-adjusted life yearMalawi Diabetic Retinopathy Study
Incremental cost-effectiveness of screening and laser treatment for diabetic retinopathy and macular edema in Malawi

基本信息

模态
表格
大小
0.004077919 GB
许可
CC BY 4.0
创建/更新时间
2018-01-05
版本
v1

资源简介

马拉维糖尿病视网膜病变和黄斑水肿筛查与激光治疗的增量成本效益分析

【数据集背景】

本数据集源站标题为《Incremental cost-effectiveness of screening and laser treatment for diabetic retinopathy and macular edema in Malawi》。配套论文《Incremental cost-effectiveness of screening and laser treatment for diabetic retinopathy and macular edema in Malawi》发表于 PLOS ONE(2018),DOI:10.1371/journal.pone.0190742。源站首次发布:2018-01-04。

【数据内容】

源站原始描述:Objective To investigate the economic impact of introducing targeted screening and laser photocoagulation treatment for sight-threatening diabetic retinopathy and macular edema in a setting with no previous screening or laser treatment for diabetic retinopathy in sub-Saharan Africa. Materials and methods A cohort Markov model was built to compare combined targeted screening and laser treatment for patients with sight-threatening diabetic retinopathy and macular edema against no intervention. Pri…

【数据结构与技术规格】

文件数 2 个,合计 4.08 MB。S1 Data.xlsx:application/vnd.openxmlformats-officedocument.spreadsheetml.sheet,549.77 KB。S1 Fig.tif:image/tiff,3.53 MB。数据集 DOI:10.1371/journal.pone.0190742。

【主题与分类】

源站学科分类:Pharmacology、Biotechnology、Chemical Sciences not elsewhere classified、Marine Biology、Science Policy、Infectious Diseases。主题标签:service utilization rate、screening、laser photocoagulation treatment、laser treatment、base case scenario、base case、macular edema、intervention、retinopathy、QALY。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://plos.figshare.com/articles/dataset/Incremental_cost-effectiveness_of_screening_and_laser_treatment_for_diabetic_retinopathy_and_macular_edema_in_Malawi/5757897

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Vetrini, Damir; Kiire, Christine A.; Burgess, Philip I.; P. Harding, Simon; Kayange, Petros C.; Kalua, Khumbo; et al. (2018). Incremental cost-effectiveness of screening and laser treatment for diabetic retinopathy and macular edema in Malawi. PLOS ONE. Dataset

【使用注意】

· 源站最后修改于 2023-06-03,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "S1 Data.xlsx" "https://ndownloader.figshare.com/files/10146399"
curl -L -o "S1 Fig.tif" "https://ndownloader.figshare.com/files/10146411"

文件清单

  • S1 Data.xlsx(549.77 KB)
  • S1 Fig.tif(3.53 MB)

文件总体积 4.08 MB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Objective
To investigate the economic impact of introducing targeted screening and laser photocoagulation treatment for sight-threatening diabetic retinopathy and macular edema in a setting with no previous screening or laser treatment for diabetic retinopathy in sub-Saharan Africa.
Materials and methods
A cohort Markov model was built to compare combined targeted screening and laser treatment for patients with sight-threatening diabetic retinopathy and macular edema against no intervention. Primary outcomes were incremental cost per quality-adjusted life year (QALY) gained and per disability-adjusted life year (DALY) averted. Primary data were collected on 357 participants from the Malawi Diabetic Retinopathy Study, a prospective, observational cohort study. Multiple scenarios were explored and a probabilistic sensitivity analysis was performed.
Results
In the base case (age: 50 years, service utilization rate: 80%), the cost of the intervention and the years of severe visual impairment averted per patient screened were $209 and 2.2 years respectively. Applying the World Health Organization threshold of cost-effectiveness for Malawi ($679), the base case was cost-effective when QALYs were used ($400 per QALY gained) but not when DALYs were used ($766 per DALY averted). The intervention was more cost-effective when it targeted younger patients (age: 30 years) and less cost-effective when the utilization rate was lowered to 50%.
Conclusions
Annual photographic screening of diabetic patients attending medical diabetes clinics in Malawi, with the provision of laser treatment for those with sight-threatening diabetic retinopathy and macular edema, appears to be cost-effective in terms of QALYs gained, in our base case scenario. Cost-effectiveness improves if services are utilized more intensively and extended to younger patients.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0190742(source: https://plos.figshare.com/articles/dataset/Incremental_cost-effectiveness_of_screening_and_laser_treatment_for_diabetic_retinopathy_and_macular_edema_in_Malawi/5757897)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案